Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
|---|---|---|---|---|---|
| C0687720 | Central Diabetes Insipidus | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0020615 | Hypoglycemia | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0020501 | Primary Hyperoxaluria | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0520459 | Necrotizing Enterocolitis | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0020459 | Hyperinsulinism | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0006826 | Malignant Neoplasms | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0086543 | Cataract | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0009691 | Congenital cataract | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C1306459 | Primary malignant neoplasm | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0376358 | Malignant neoplasm of prostate | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0023467 | Leukemia, Myelocytic, Acute | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0525045 | Mood Disorders | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0006142 | Malignant neoplasm of breast | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0004364 | Autoimmune Diseases | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0345904 | Malignant neoplasm of liver | CRYL1 | 51084 | crystallin lambda 1 | Q9Y2S2 |
| C0282577 | Congenital Disorders of Glycosylation | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0024141 | Lupus Erythematosus, Systemic | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0870082 | Hyperkeratosis | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0025958 | Microcephaly | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0036572 | Seizures | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0033860 | Psoriasis | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0008312 | Primary biliary cirrhosis | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C3553230 | CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C2242776 | Plexiform leiomyoma | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
| C0235946 | Cerebral atrophy | COG6 | 57511 | component of oligomeric golgi complex 6 | Q9Y2V7 |
